Summit Therapeutics

SMMT • NASDAQ • Stock Fundamentals

Summit Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert W. Duggan, with a market cap of $12.9B.

Market Cap$12.9B

Employees105.0

CEORobert W. Duggan

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsApr 30, 2026 · 26 days agoQ1 2026

Next EarningsAug 10, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Summit Therapeutics

Summit Therapeutics (SMMT) has a market capitalization of $12.9B and trades on NASDAQ.

Summit Therapeutics has approximately 105 employees.